U.S. Health and Human Services Secretary Robert F. Kennedy Jr. speaks at an event on lowering drug prices, in the Oval Office at the White House, on Nov. 06.

The Trump administration is asking drugmakers to share confidential details of contracts they have signed with insurers in Canada and other developed countries as it pushes pharmaceutical companies to lower their U.S. prices and raise them in Canada and elsewhere.

The U.S. government plans to use the information it is seeking to set prices for reimbursement under Medicaid, the state-and-federal health insurance for low-income residents. Drugmakers who volunteer to join the new program would have streamlined, easier access to being listed by state drug plans.

Details of the initiative, called the “GENErating cost Reductions fOr U.

See Full Page